Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009

Jiu-Song Zhang1, Qiu-Min Zhao, Xiao-Fang Guo

  • 1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China. zhang_jiusong@yahoo.com.cn

Plos One
|February 2, 2011
PubMed
Abstract

Insights

Genotype 1 Japanese encephalitis virus (JEV) has been isolated from human patients in China, challenging previous assumptions about its role in human disease. Further research is needed to assess vaccine efficacy against this emerging JEV genotype.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Japanese encephalitis virus (JEV) is a significant cause of viral encephalitis in Asia.
  • Chinese JEV strains are evolving from genotype 3 to genotype 1.
  • Genotype 1 JEV has been primarily isolated from mosquitoes, with limited association with human disease.

Purpose of the Study:

  • To report the isolation and genetic characterization of human genotype 1 JEV strains from China.
  • To provide insights into the JEV pathogens currently circulating in China.

Main Methods:

  • Cerebrospinal fluid samples were collected from patients in Yunnan and Shanxi provinces.
  • Virus isolation was performed using Aedes albopictus C6/36 cells.
  • JEV strains were identified using immunofluorescent assays and RT-PCR.
  • Phylogenetic analyses were conducted on capsid/pre-membrane and envelope (E) gene sequences.

Main Results:

  • Three JEV isolates of genotype 1 were obtained from human patients.
  • The isolates showed high amino acid identity (95-100%) in the viral E protein.
  • Two specific amino acid substitutions were identified in the E protein compared to a consensus sequence.

Conclusions:

  • Genotype 1 JEV is capable of causing human infections in China.
  • A vaccinated boy developed JE from genotype 1 infection, suggesting potential vaccine escape.
  • Further in vitro and in vivo studies are needed to evaluate the protective efficacy of the live attenuated JE vaccine against genotype 1.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...